Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

75.86
Delayed Data
As of Jun 26
 +0.58 / +0.77%
Today’s Change
65.47
Today|||52-Week Range
99.14
-8.85%
Year-to-Date
No recent news for Perrigo Company PLC.

Today’s Trading

Previous close75.28
Today’s open75.71
Day’s range75.58 - 77.74
Volume1,887,632
Average volume (3 months)2,001,100
Market cap$10.9B
Dividend yield0.84%
Data as of 06/26/2017

Growth & Valuation

Earnings growth (last year)-36,609.52%
Earnings growth (this year)-15.48%
Earnings growth (next 5 years)+5.85%
Revenue growth (last year)-4.71%
P/E ratio16.0
Price/Sales2.26
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...0.000.00%
ALKSAlkermes Plc-0.17-0.29%
SGENSeattle Genetics Inc-5.19-8.41%
TSROTESARO Inc-0.01-0.01%
Data as of 06/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.91
Annual revenue (last year)$5.3B
Annual profit (last year)-$4.0B
Net profit margin-76.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer
Ron L. Winowiecki
Corporate headquarters
Dublin, Dublin

Forecasts